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Introduction
ESBLs	enzimes	confer	resistance	to	extended-
spectrum	cephalosporins	(ESCs)	and	monobactams	
and	 often	 express	 a	 resistance	 to	 non-β-lactam	
antimicrobials	 such	 as	 fluoroquinolones	 leaving	
only	 limited	 therapeutic	 options	 (Pitout	 et al.,	
2008).	 Escherichia coli	 strains	 colonize	 the	
digestive	 track	 both	 in	 animals,	 and	 in	 humans.	
Resistance	 to	 ESC	 is	 one	 of	 the	 characteristics	
commonly	 seen	 in	 E. coli	 strains,	 representing	
an	 issue	 both	 for	 human	 and	 animal	 health	
(Ljungquist	 et al.,	 2016).	 The	 change	 of	 faecal	
microbiota	in	dogs,	with	increased	resistance	and	
carriage	of	ESBL	producing	E. coli	isolates	is	more	
prevalent	 	 with	 most	 dogs	 being	 intermittently	
shedders	 and	 positive	 carriers	 for	 various	 ESBL	
genes	 (Baede	 et al.,	 2015).	 Several	 studies	 have	
shown	that	the	most	common	type	of	ESBL	enzyme	
isolated	from	dog	faecal	microbiota	was	CTX-M-15	
a	 predominant	 subtype	 both	 in	 humans	 and	 in	
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Abstract	
 The	aim	of	this		study	was	to	determine	the	prevalence	of	β-lactamase	(TEM,	SHV,	OXA),	extended-spectrum	
β-lactamase	(ESBL)	and	genes	encoding	plasmid	mediated	resistance	to	quinolones	(PMQR)	in	extended	spectrum	
cephalosporin	 (ESC)-resistant	Escherichia coli	 isolated	 from	dog	 faeces	 from	 two	 shelters	 in	 the	North-East	 of	
Romania.	 Eighty-eight	faecal	samples	from	healthy	dogs	were	analysed	by	cultivation	on	Brilliance	ESBL	
medium	(Oxoid,	UK),	followed	by	phenotipic	ESBL	screening	using	combination	disc	test	(CDT).	Identification	of	
the	E. coli	strains	was	performed	by	uidA/uspA	gene	PCR.	Susceptibility	testing	was	performed	on	Mueller-Hinton	
Agar,	with	β-lactam	and	non-β-lactam	agents.	 Identification	of	β-lactamase	genes	 (bla
CTX-M
,	blaTEM,	blaSHV,	blaOXA)	
and	PMQR	genes	(qnrA, qnrB	and qnrS)	was	performed	by	PCR	as	previously	described.	 Twenty	 eight	 ESC-
resistant	E. coli	 (31.81%)	were	obtained	and	 (n=21/28,	 	75%)	of	 these	were	confirmed	as	ESBLs	and	showed	
resistance	 to	 cefpodoxime	 (n=21/28,	 75%),	 amoxicillin/clavulanic	 acid	 (n=19/21;	 90.48%),	 and	 	 enrofloxacin	
(n=8/21;	38.09%).	Predominant	ESBL	types	were	CTX-M-1	(n=15/17,	88.24%)	and	CTX-M-9	(n=2/17,	11.76%)	
enzymes.	TEM	and	SHV	enzymes	were	identified	in	17.86%	and	14.29%	of	the	ESC-resistant	isolates,	whilst	some	
isolates	(n=4)	carried	only	blaTEM	and	blaSHV.	The	prevalence	of	PMQR	genes	was	28.57%	of	the	28	ESC	resistant	
isolates,	consisting	of	qnrS	(62.5%)	and	qnrB	(37.5%).		 These	findings	indicate	a	high	prevalence	of	ESBLs	and	
PMQR	associated	resistance	E. coli	in	the	normal	faecal	microbiota	of	dogs	from	shelters,	which	carries	the	risk	for	
dissemination	of	these	resistance	genes	to	other	animals,	human	or	the	environment.
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animals,	 including	 in	 livestock	 and	wild	 animals	
(Brolund	et al.,2016;	Ewers	et al.,	2012;	Guenther	
et al.,	 2011).	 Bacterial	 resistance	 to	 antibiotics,	
seen	 in	 Enterobacteriaceae	 strains	 isolated	 from	
dogs,	 may	 represent	 a	 potential	 risk	 for	 public	
health	 due	 to	 potential	 of	 being	 a	 	 reservoir	 of	
resistant	bacteria	 for	people	with	whom	animals	
may	 come	 in	 direct	 contact	 (physical	 injuries,	
petting	licking)	or	indirect	contact	(contamination	
of	 the	 household	 environment)	 (Guardabassi	 et 
al.,	2004).	With	the	exception	of	a	study	looking	at	
antibiotic	resistance	of	E. coli	strains	isolated	from	
chicken	(Măciucă	et al.,	2015)	characterization	of	
ESC-resistance	resistance	in	animals	has	received	
less	attention	in	Romania.
The	 aim	 of	 this	 work	 was	 to	 characterise	
antimicrobial	 resistance	 among	 E. coli	 isolated	
from	dog	 faeces	 from	 two	 shelters	 in	 the	North-
East	 of	 Romania,	with	 an	 emphasis	 on	 extended	
spectrum	 cephalosporin	 (ESC)	 resistance.	 The	
main	 focuse	was	 to	 determine	 the	 prevalence	 of	
β-lactamase	(TEM,	SHV,	OXA),	extended-spectrum	
β-lactamase	 (ESBL)	 and	 genes	 encoding	plasmid	
mediated	resistance	to	quinolones	(PMQR)	in	ESC-
resistant	E. coli	isolated	from	healthy	dogs.
Materials and methods
Eighty-eight	 faecal	 samples	 were	 collected	
from	 healthy	 dogs	 from	 two	 shelters	 from	 the	
North-East	of	Romania	using	sterile	rectal	swabs.	
The	 primary	 processing	 consisted	 of	 performing	
the	 E. coli	 ESBL	 producing	 screening	 using	 the	
Brilliance	 ESBL	 medium	 (Oxoid,	 Basingstoke,	
UK),	 a	medium	 that	 contains	 cefpodoximes.	 The	
isolates	 that	 generated	 colonies	 characteristic	
of	E. coli	on	the	medium	used	for	screening	were	
molecularly	 confirmed	 as	 being	 E. coli	 based	
on	 the	 uidA	 and	 uspA genes (McDaniels	 et al.,	
1996;	 Anastasi et al.,	 2010)	 and	 phenotypically	
confirmed	 as	 being	 ESBL	 using	 the	 combination	
disc	 test	 (CDT)	 (	 MAST	 Group,	 UK).	 Also,	 all	 E. 
coli	 isolated	 on	 the	 Brilliance	 ESBL	 medium	
were	 tested	 for	 susceptibility	 to	 β-lactam	 and	
non-β-lactam	 agents	 through	 the	 diffusimetric	
method	using	Mueller-Hinton	Agar	(all	disks	and	
media	 from	 Oxoid,	 UK).	 The	 ATCC	 25922	E. coli 
strain	was	used	as	control	 	 for	 the	disk	diffusion	
susceptibility	test.	The	antimicrobials	tested	were	
as	the	follows:	amoxicillin/clavulanic	acid	(30μg),	
ampicillin	 (10μg),	 aztreonam	 (30μg),	 imipenem	
(10μg),	 trimethoprim/sulfamethoxazole	 (25µg),	
en	ro	floxacin	 (5μg),	 tetracycline	 (30μg),	 chloram-
phenicol	(30μg)	and	gentamicin	(10μg).
Cell	 lysates	 obtained	 from	 all	 investigated	
isolates	 were	 screened	 by	 PCR	 for	 the	 presence	
of	genes	encoding	for	β-lactamase	genes	(bla
CTX-M
,	
blaTEM,	 blaSHV,	 blaOXA)	 and	 PMQR	 (qnrA, qnrB	 and 
qnrS)	 	 as	 previously	 described	 	 (Wedley	 et al.,	
2011;	Dallenne	et al.,	2010;	Robicsek	et al.,	2006).	
A	 PCR	 scheme	 described	 by	 Clermont	 et	 al	
was	used	to	assign	the	ESBL		E. coli	isolates	to	one	
of	the	4	main	phylogenetic	groups	(A,	B1,	B2,	D).	
(Clermont	et al.,	2000)	
Results and discussions
Eighty-eight	 faecal	 samples	 collected	 from	
the	 two	shelters	were	analysed	and	screened	 for	
ESBL	 production.	 Results	 showed	 that	 ,	 28/88	
(31.81%)	 ESC-resistant	 E. coli	 isolates	 	 were	
obtained	 and,	 of	 these,	 21	 isolates	 (75%)	 were	
phenotypically	 confirmed	 as	 extended-spectrum	
β-lactamase	 enzyme-producing	 strains.	 The	
antimicrobial	 susceptibility	 test	 was	 carried	 out	
for	 the	 21	 phenotypically	 positive	 ESBL	 isolates	
which	 demonstrated	 high	 levels	 of	 resistance	 to	
ampicillin	(100%	of	them),	amoxicillin/clavulanic	
acid	 (90.48%;	 19/21),	 aztreonam	 (85.71%;	
18/21)	 and	 tetracycline	 (47.62%;	 10/21).	 In	
addition,	 38.09%	 (8/21)	 of	 isolates	 were	 was	
resistant	to	both	enrofloxacin	and		trimethoprim/
sulfamethoxazol	 whilst	 14.29%	 (3/21)	 were	
resistant	to	chloramphenicol.	All	strains	analysed	
using	 the	 diffusimetric	 test	 were	 susceptible	 to	
imipenem	and	chloramphenicol.
	Molecular	testing	showed	that		bla
CTX-M	
genes	
were	identified	in	17/28	(60.71%)	of	ESC-resistant	
E. coli	 isoaltes,	 15	 of	which	 	 (88.24%)	 belonged	
to	 the	CTX-M-1	group	and	only	 two	 (11.76%)	 to	
the	CTX-M-9	group.	No	genes	belonging	to	groups	
bla
CTX-M-2
,	 bla
CTX-M-8
,	 and	 bla
CTX-M-25	 	
were	 identified.	
In	addition,	5/28	(17.86%)	E. coli	isolates		carried	
blaTEM,	 and	 4/28	 (14.29%)	 carrying	 blaSHV	were	
identified,	 while	 bla
OXA	
was	 not	 identified	 in	 any	
ESC-resistant	E. coli	strain	(table 1).
The	investigations	for	the	PMQR	genes	showed	
that	8/28	(28.57%)	of	the	analysed	isolates	were	
positive,	 qnrS	 being	 the	 most	 prevalent	 gene,	
which	was	 carried	 by	 5/8	 (62.5%)	 isolates;	 this	
was	 followed	by	qnrB,	which	was	carried	by	3/8	
(37.5%)	ESC-resistant	E. coli (table	1).	 The	qnrA 
was	not	identified	for	the	analysed	isolates.
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In	regard	to	the	identified	gene	combinations,	
bla
CTX-M-1		
has	been	identified	both	in	combinations	
with	 PMQR	 genes	 (qnrS, qnrB, TEM)	 and	 alone	
for	7	of	the	15	carrying	bla
CTX-M-1	
isolates(table	1).	
Also,	4	of	the	28	of	E.	coli	analysed	only	harboured	
blaTEM and	blaSHV	gene	combination.
Phylogenetic	 analysis	 showed	 that	 most	
ESC-resistant	 E. coli	 isolates	 belonged	 to	 the	
phylogenetic	group	A	 (12/28;	42.86%),	 followed	
by	group	B1	(10/28;	35.71%),	B2	(4/28;	14.29%)	
and	the	phylogenetic	group	D	(2/28;	7.14%).
All	CTX-M	enzymes	are	part	of	the	extended-
spectrum	 β-lactamase	 (ESBL)	 enzyme	 group,	
while	the	TEM	and	SHV	enzymes,	could	be	either	
β-lactamase	or	ESBLs	(Ewers	et al.,	2011).	Although	
we	 did	 not	 perform	 PCR	 product	 sequencing	
on	 the	 4	 of	 the	 28	 ESC-resistant	 E. coli isolates	
which	carries	blaTEM	and	blaSHV	genes,	phenotypic	
combination	disc	test	(CDT)	testing	showed	a	typic	
ESBL	 phenotype	 in	 this	 isolates.	 Consequently,	
this	study	has	identified	a	high	prevalence	(21/28;	
75%)	 of	 extended-spectrum	 β-lactamase	 (ESBL)	
enzyme-producing	E. coli	isolates	associated	with	
the	 production	 of	 genes	 encoding	 the	 plasmid	
mediated	resistance	to	quinolones,	in	the	normal	
microbiota	of	healthy	dogs.
Also,	in	our	study,	the	most	prevalent	enzyme	
group	was	CTX-M-1,	which	was	the	most	common	
enzyme	identified	in	chicken,	pets	and	also	urban	
healthy	 dogs	 (Dahmen	 et al.,	 2012;	 Grami	 et al.,	
2013;	Zurfluh	et al.,	2014;	Haenni	et al.,	2014).
Although	 the	number	of	analysed	samples	 is	
small,	the	high	prevalence	of	ESBL	positive	E. coli 
isolates	 	 	 identified	 in	 this	 study	 highlights	 the	
occurance	 and	 likely	 circulation	 of	 these	 genes	
among	 healthy	 animals	 from	 shelters.	 This	 may	
also	 suggest	 that	 the	 unresricted	 circulation	 of	
these	 dogs	 could	 facilitate	 the	 dissemination	
of	 these	 resistance	 isolates/genes	 in	 animal	
populations	and	between	species.
Finally,		the	identification	and	characterisation	
of	 the	 main	 genes	 encoding	 ESBL	 enzymes	
in	 dog	 populations,	 stray	 or	 pets	 in	 Romania	
has	 epidemiological	 imporatance	 as	 this	 is	
the	 first	 study	 to	 evaluate	 their	 prevalence	 in	
this	 population.	 Knowledge	 of	 the	 sources	 and	
reservoirs	 for	 these	 genes	 is	 essential	 in	 order	
to	 reduce	 the	 risks	 of	 transmission	 to	 humans.	
In	 addition,	 better	 policies	 and	 guidelines	 for	
apppropriate	 antimicrobial	 use	 are	 critical	 and	
need	 to	 be	 implemented	 in	 Romania	 to	 reduce	
the	 impact	 of	 selective	 pressure	 associated	with	
antimicrobial	use	in	veterinary	medicine.
Conclusions
These	 findings	 indicate	 a	 high	 prevalence	
of	 ESBLs	 and	PMQR	associated	 resistance	E. coli 
Table 1.	 Prevalence	 and	 distribution	 of	 resistance	 gene	 combinations	 in	Enterobacteriaceae	 strains	
isolated
Source bla gene combinations No. of isolates/group
dog
Total CTX-M (%)* 17/28 (60.71%)
CTX-M-1 group (%) 15/17 (88.24%)
CTX-M-1 7/15	(46.66%)
CTX-M-1,	qnrS 4/15	(26.67%)
CTX-M-1,	qnrS,	TEM 1/15	(6.67%)
CTX-M-1,	qnrB 3/15	(20%)
CTX-M-9 group (%)* 2/17 (11.76%)
Total TEM (%)* 5/28 (17.86%)
TEM,	SHV 4/28	(14.29%)
Total SHV (%) * 4/28 (14.29%)
Total PMQR genes 8/28 (28.57%)
qnrS 5/8	(62.5%)
qnrB 3/8	(37.5%)
Note:	*	is	the	percentage	of	the	screened	gene	present	in	any	combination	in	the	analysed	groups	(dogs)
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in	 the	 normal	 microbiota	 of	 dogs	 from	 shelters,	
which	 carries	 the	 risk	 for	 dissemination	 of	
resistance	genes	to	other	animals,	humans	or	the	
environment.
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